| Biological Sciences | Lifetime | 683 | CN 18 | 99.92 |
| Biological Sciences | 2021-2025 | 77 | CN 29 | 99.93 |
| Medical and Health Sciences | 2021-2025 | 248 | CN 27 | 99.95 |
| Epidemiology | Lifetime | 368 | CN 11 | 99.54 |
| Molecular Biology | Lifetime | 807 | CN 39 | 99.57 |
| Immunology | Lifetime | 231 | CN 4 | 99.44 |
| Critical Care and Intensive Care Medicine | Lifetime | 45 | CN 1 | 99.19 |
| Medical Physiology | Lifetime | 574 | CN 9 | 99.02 |
| Pulmonary and Respiratory Medicine | Lifetime | 751 | CN 15 | 98.87 |
| Cancer Research | Lifetime | 341 | CN 26 | 97.99 |
| Pathology and Forensic Medicine | Lifetime | 481 | CN 7 | 97.95 |
| Neuroscience of Neurology | Lifetime | 343 | CN 12 | 97.33 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 819 | CN 13 | 97.02 |
| Pharmacology | Lifetime | 356 | CN 30 | 96.45 |
| Cellular and Molecular Neuroscience | Lifetime | 835 | CN 16 | 95.99 |
| Endocrine and Autonomic Systems | Lifetime | 299 | CN 6 | 94.88 |
| Clinical Biochemistry | Lifetime | 389 | CN 9 | 93.10 |
| Complementary and Alternative Medicine | Lifetime | 771 | CN 65 | 92.62 |
| Nephrology | Lifetime | 626 | CN 22 | 92.46 |
| Emergency Medicine | Lifetime | 822 | CN 5 | 90.43 |
| Obstetrics and Gynecology | Lifetime | 984 | CN 20 | 79.72 |
| Developmental Neuroscience | Lifetime | 495 | CN 20 | 73.98 |
| Immunology | 2021-2025 | 20 | CN 3 | 99.54 |
| Molecular Biology | 2021-2025 | 97 | CN 44 | 99.61 |
| Epidemiology | 2021-2025 | 139 | CN 15 | 99.10 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 124 | CN 17 | 99.19 |
| Surgery | 2021-2025 | 301 | CN 21 | 97.99 |
| Medical Physiology | 2021-2025 | 184 | CN 9 | 97.69 |
| Neuroscience of Neurology | 2021-2025 | 112 | CN 17 | 94.30 |
| Cancer Research | 2021-2025 | 120 | CN 42 | 94.52 |
| Pathology and Forensic Medicine | 2021-2025 | 243 | CN 31 | 92.92 |
| Oncology | 2021-2025 | 523 | CN 60 | 92.83 |
| Clinical Biochemistry | 2021-2025 | 51 | CN 5 | 86.46 |
| Critical Care and Intensive Care Medicine | 2021-2025 | 135 | CN 4 | 85.85 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 712 | CN 88 | 83.48 |
| Nephrology | 2021-2025 | 268 | CN 24 | 80.59 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 592 | CN 23 | 76.85 |
| Sepsis Diagnosis and Treatment | Lifetime | 45 | CN 1 | 99.74 |
| Thermal Regulation in Medicine | Lifetime | 19 | CN 1 | 99.33 |
| Immune Response and Inflammation | Lifetime | 127 | CN 3 | 99.62 |
| MicroRNA in disease regulation | Lifetime | 191 | CN 62 | 99.18 |
| Phagocytosis and Immune Regulation | Lifetime | 36 | CN 1 | 99.07 |
| Trauma, Hemostasis, Coagulopathy, Resuscitation | Lifetime | 38 | CN 1 | 99.27 |
| Cancer-related molecular mechanisms research | Lifetime | 312 | CN 141 | 98.88 |
| Immune cells in cancer | Lifetime | 146 | CN 13 | 99.04 |
| Inflammasome and immune disorders | Lifetime | 85 | CN 6 | 98.81 |
| Inflammation biomarkers and pathways | Lifetime | 13 | CN 1 | 98.58 |
| Renal function and acid-base balance | Lifetime | 84 | CN 1 | 98.56 |
| Cancer, Stress, Anesthesia, and Immune Response | Lifetime | 63 | CN 3 | 97.72 |
| Circular RNAs in diseases | Lifetime | 200 | CN 110 | 98.48 |
| Cardiac Ischemia and Reperfusion | Lifetime | 183 | CN 6 | 98.58 |
| Neuropeptides and Animal Physiology | Lifetime | 329 | CN 6 | 98.73 |
| Intensive Care Unit Cognitive Disorders | Lifetime | 239 | CN 3 | 98.64 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 149 | CN 2 | 98.44 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 413 | CN 25 | 98.60 |
| Advanced Glycation End Products research | Lifetime | 170 | CN 16 | 97.43 |
| Receptor Mechanisms and Signaling | Lifetime | 751 | CN 16 | 98.29 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 546 | CN 9 | 97.76 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 530 | CN 4 | 97.36 |
| Regulation of Appetite and Obesity | Lifetime | 432 | CN 8 | 97.45 |
| Traumatic Brain Injury and Neurovascular Disturbances | Lifetime | 863 | CN 15 | 97.76 |
| Anesthesia and Neurotoxicity Research | Lifetime | 553 | CN 30 | 96.80 |
| Extracellular vesicles in disease | Lifetime | 543 | CN 169 | 96.02 |
| Pharmacological Effects of Natural Compounds | Lifetime | 621 | CN 171 | 96.22 |
| S100 Proteins and Annexins | Lifetime | 366 | CN 7 | 96.45 |
| Hormonal Regulation and Hypertension | Lifetime | 867 | CN 15 | 96.74 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 658 | CN 22 | 96.36 |
| Biochemical effects in animals | Lifetime | 748 | CN 65 | 95.61 |
| Erythrocyte Function and Pathophysiology | Lifetime | 868 | CN 8 | 95.81 |
| Cell death mechanisms and regulation | Lifetime | 684 | CN 40 | 95.62 |
| Electrolyte and hormonal disorders | Lifetime | 560 | CN 5 | 95.57 |
| Ferroptosis and cancer prognosis | Lifetime | 799 | CN 466 | 93.34 |
| Heme Oxygenase-1 and Carbon Monoxide | Lifetime | 498 | CN 19 | 95.12 |
| Traditional Chinese Medicine and Integrative Care | Lifetime | 367 | CN 231 | 89.87 |
| Hydrogen's biological and therapeutic effects | Lifetime | 113 | CN 22 | 92.12 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 577 | CN 3 | 93.78 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 860 | CN 105 | 93.78 |
| Signaling Pathways in Disease | Lifetime | 862 | CN 49 | 92.81 |
| NF-κB Signaling Pathways | Lifetime | 925 | CN 66 | 92.97 |
| Apelin-related biomedical research | Lifetime | 365 | CN 22 | 91.51 |
| Vagus Nerve Stimulation Research | Lifetime | 369 | CN 28 | 89.50 |
| Neonatal and Maternal Infections | Lifetime | 991 | CN 37 | 88.57 |
| Medicinal Plants and Bioactive Compounds | Lifetime | 492 | CN 157 | 82.03 |
| Medicinal Plant Pharmacodynamics Research | Lifetime | 641 | CN 427 | 74.54 |
| Clusterin in disease pathology | Lifetime | 903 | CN 86 | 44.49 |
| Immune Response and Inflammation | 2021-2025 | 3 | CN 2 | 99.63 |
| Inflammasome and immune disorders | 2021-2025 | 12 | CN 5 | 99.02 |
| Thermal Regulation in Medicine | 2021-2025 | 4 | CN 1 | 97.77 |
| Inflammation biomarkers and pathways | 2021-2025 | 2 | CN 1 | 97.73 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | 2021-2025 | 15 | CN 4 | 96.70 |
| Phagocytosis and Immune Regulation | 2021-2025 | 15 | CN 5 | 96.02 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 68 | CN 2 | 98.56 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 104 | CN 8 | 98.24 |
| MicroRNA in disease regulation | 2021-2025 | 197 | CN 125 | 97.34 |
| Cancer-related molecular mechanisms research | 2021-2025 | 440 | CN 335 | 96.46 |
| Signaling Pathways in Disease | 2021-2025 | 19 | CN 8 | 93.15 |
| Extracellular vesicles in disease | 2021-2025 | 347 | CN 213 | 94.79 |
| Immune cells in cancer | 2021-2025 | 396 | CN 216 | 93.13 |
| Neuroinflammation and Neurodegeneration Mechanisms | 2021-2025 | 393 | CN 125 | 93.71 |
| Cardiac Ischemia and Reperfusion | 2021-2025 | 67 | CN 19 | 93.05 |
| Traditional Chinese Medicine and Integrative Care | 2021-2025 | 19 | CN 15 | 82.69 |
| S100 Proteins and Annexins | 2021-2025 | 95 | CN 11 | 87.74 |
| Adipose Tissue and Metabolism | 2021-2025 | 633 | CN 131 | 89.87 |
| Neonatal Respiratory Health Research | 2021-2025 | 842 | CN 38 | 91.55 |
| Ferroptosis and cancer prognosis | 2021-2025 | 939 | CN 796 | 89.84 |
| Adipokines, Inflammation, and Metabolic Diseases | 2021-2025 | 361 | CN 68 | 86.46 |
| interferon and immune responses | 2021-2025 | 599 | CN 337 | 85.18 |
| Neurological Disease Mechanisms and Treatments | 2021-2025 | 368 | CN 147 | 84.26 |
| Erythrocyte Function and Pathophysiology | 2021-2025 | 293 | CN 36 | 84.99 |
| Mycobacterium research and diagnosis | 2021-2025 | 728 | CN 114 | 85.21 |
| Occupational and environmental lung diseases | 2021-2025 | 330 | CN 41 | 84.88 |
| Advanced Glycation End Products research | 2021-2025 | 221 | CN 97 | 82.17 |
| Acute Kidney Injury Research | 2021-2025 | 564 | CN 150 | 82.61 |
| Anesthesia and Neurotoxicity Research | 2021-2025 | 551 | CN 177 | 79.24 |
| Genomics, phytochemicals, and oxidative stress | 2021-2025 | 580 | CN 200 | 75.78 |
| Neonatal and Maternal Infections | 2021-2025 | 446 | CN 41 | 72.10 |
| Acupuncture Treatment Research Studies | 2021-2025 | 696 | CN 466 | 72.00 |
| Effects of Radiation Exposure | 2021-2025 | 673 | CN 103 | 68.72 |
| Protease and Inhibitor Mechanisms | 2021-2025 | 564 | CN 146 | 65.73 |
| Cell death mechanisms and regulation | 2021-2025 | 481 | CN 128 | 58.58 |
| Medicinal Plants and Bioactive Compounds | 2021-2025 | 514 | CN 225 | 52.13 |
| Heat shock proteins research | 2021-2025 | 873 | CN 203 | 50.17 |
| Wnt/β-catenin signaling in development and cancer | 2021-2025 | 761 | CN 208 | 48.15 |